Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Cristina Oliani"'
Autor:
Davide Serrano, Paola Patrignani, Vittoria Stigliano, Daniela Turchetti, Stefania Sciallero, Franco Roviello, Alessandro D’Arpino, Ignazio Grattagliano, Salvo Testa, Cristina Oliani, Lucio Bertario, Bernardo Bonanni
Publikováno v:
Genes, Vol 13, Iss 3, p 460 (2022)
Cancer prevention in the era of precision medicine has to consider integrated therapeutic approaches. Therapeutic cancer prevention should be offered to selected cohorts with increased cancer risk. Undoubtedly, carriers of hereditary cancer syndromes
Externí odkaz:
https://doaj.org/article/85b7d8a1cefe41808abfaf295770ae4b
Autor:
Andrea Remo, Guglielmina Nadia Ranzani, Maria Grazia Tibiletti, Valentina Calò, Giulia Cini, Emanuele Damiano Luca Urso, Cristina Oliani, Ileana Carnevali, Emanuela Lucci Cordisco
Publikováno v:
European Journal of Cancer Prevention. 31:44-49
Publikováno v:
Psycho-Oncology. 30:385-391
Objective Burnout may represent a significant source of distress in health care professionals. Many studies have reported its negative effect on career satisfaction and personal life. The aim of the present study was to investigate the relation betwe
Autor:
Maria V, Dieci, Giuseppe, Azzarello, Vittorina, Zagonel, Franco, Bassan, Stefania, Gori, Giuseppe, Aprile, Vanna, Chiarion-Sileni, Sara, Lonardi, Cristina, Oliani, Marta, Zaninelli, Rita, Chiari, Adolfo, Favaretto, Alberto, Pavan, Elisabetta, Di Liso, Eleonora, Mioranza, Alessandra, Baldoni, Francesca, Bergamo, Marco, Maruzzo, Stamatia, Ziampiri, Alessandro, Inno, Filomena, Graziani, Giusy, Sinigaglia, Michele, Celestino, Pierfranco, Conte, Valentina, Guarneri
We analyzed a cohort of patients with cancer and Sars-Cov-2 infection from the Veneto Oncology Network registry across two pandemic time periods.761 patients with cancer and SARS-CoV-2 infection were included.198 patients were diagnosed during the fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::50d98b24d35ef9d32def250f426e169a
http://hdl.handle.net/11577/3456283
http://hdl.handle.net/11577/3456283
Autor:
Emanuele Damiano Luca Urso, Maurizio Ponz de Leon, Marco Vitellaro, Guglielmo Niccolò Piozzi, Quoc Riccardo Bao, Aline Martayan, Andrea Remo, Vittoria Stigliano, Cristina Oliani, Emanuela Lucci Cordisco, Salvatore Pucciarelli, Guglielmina Nadia Ranzani, Alessandra Viel, Francesca Adami, Elisa Alducci, Lucia Amadori, Valentina Arcangeli, Luisa Balestrino, Daniela Barana, Lucio Bertario, Bernardo Bonanni, Stefania Boni, Pierluigi Bullian, Fiorella Carbonardi, Ileana Carnevali, Paola Castelli, Francesco Celotto, Giulia Cini, Gino Crivellari, Duilio Della Libera, Anastasia Dell'elice, Maria Digennaro, Alessandra D'urso, Antonella Fabretto, Daniele Fanale, Irene Feroce, Daniela Furlan, Paola Ghiorzo, Mara Giacché, Milena Gusella, Barbara Liserre, Isabella Mammi, Stefania Massuras, Daniela Mazzà, Eleonora Mollica, Alberto Morabito, Giorgia Nardo, Flavia Palermo, Elena Panizza, Margherita Patruno, Monica Pedroni, Valeria Grazia Maria Pensotti, Guglielmo Niccolo Piozzi, Simonetta Pozzi, Silvia Presi, Marta Puzzono, Mila Ravegnani, Maria Teresa Ricci, Luca Roncucci, Giovanni Battsita Rossi, Elena Maria Sala, Lupe Sanchez Mete, Daniele Sandonà, Stefania Sciallero, Davide Serrano, Stefano Signoroni, Francesca Spina, Monica Taborelli, Gianluca Tedaldi, Maria Grazia Tibiletti, Silvia Tognazzo, Gianluca Tolva, Cristina Maria Concetta Trovato, Daniela Turchetti, Dora Varvara, Caterina Vivanet, Stefania Zovato, Raffaella Alessia Zuppardo
An expert consensus panel convened by the Italian Association for Inherited and Familial Gastrointestinal Tumors (Associazione Italiana per lo Studio della Familiarita ed Ereditarieta dei Tumori Gastrointestinali, AIFEG) reviewed the literature and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f531438840439dfae0dfb7c41cf93d16
http://hdl.handle.net/11577/3409650
http://hdl.handle.net/11577/3409650
Autor:
Cristina Falci, Cristina Oliani, Yasmina Modena, Barbara Corso, Caterina Modonesi, Silvia Toso, Donatella Da Corte Z, Elisabetta Cretella, AnnaPaola Fraccon, Antonella Brunello, Romana Segati, Laura Bertolaso, Milena Gusella, Carmen Barile, Roberto Padrini, Felice Pasini, Giovanni De Rosa, Nadia Minicuci
Publikováno v:
Pharmacology Research & Perspectives
In previous studies, steady‐state Z‐endoxifen plasma concentrations (ENDOss) correlated with relapse‐free survival in women on tamoxifen (TAM) treatment for breast cancer. ENDOss also correlated significantly with CYP2D6 genotype (activity scor
Autor:
Vanna Chiarion-Sileni, Marta Zaninelli, Alberto Pavan, Arianna Fumagalli, Giuseppe Azzarello, Mario Caccese, Rita Chiari, Pierfranco Conte, Franco Bassan, Valentina Guarneri, Maria Vittoria Dieci, Davide Pastorelli, Cristina Oliani, Stefania Gori, Daniele Bernardi, Vittorina Zagonel, Anna Roma, Michele Celestino, Adolfo Favaretto
Publikováno v:
Journal of Clinical Oncology. 39:6511-6511
6511 Background: Since the beginning of the COVID-19 outbreak, the Veneto Oncology Network ROV licensed dedicated guidelines for cancer patients care during the pandemic, and developed a regional registry (ROVID) aimed at describing epidemiology and
Autor:
Giulia Pasello, Stefania Gori, Petros Giovanis, Francesco Rosetti, Fable Zustovich, Andrea Bonetti, Laura Bonanno, Adolfo Favaretto, Carlo Gatti, Antonio Santo, Valentina Guarneri, Zora Baretta, Giovanni Palazzolo, Cristina Oliani, Jessica Menis, Roberta Redelotti, Silvia Toso, Donatella Da Corte, Giovanni Vicario, Pierfranco Conte, Alberto Bortolami, Daniele Bernardi, Stefano Frega, Francesco Oniga, Lorenzo Calvetti, Marco Basso
Introduction Gefitinib, erlotinib, and afatinib represent the approved first-line options for epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Because pivotal trials frequently lack external validity, real-world data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c624404b366ec4e1366ccb94e689159
https://europepmc.org/articles/PMC6656504/
https://europepmc.org/articles/PMC6656504/
Autor:
Gaia Griguolo, Enrico Orvieto, L. Merlini, Fable Zustovich, Paola Del Bianco, Maria Vittoria Dieci, Emilio Bria, Marta Mion, Tommaso Giarratano, Cristina Oliani, Stefania Gori, Silvia Michieletto, Gian Luca De Salvo, Paolo Morandi, Valentina Guarneri, Tania Saibene, Pierfranco Conte, Pierluigi Bullian
Background The ROXANE Italian prospective study evaluated the impact of the 21-gene Recurrence Score (RS) results on adjuvant treatment decision for patients with early breast cancer. Materials and Methods Nine centers participated. Physicians used t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d28e88e498e2867abb867c4736e01f60
http://hdl.handle.net/10807/139996
http://hdl.handle.net/10807/139996
Autor:
Laura Ottini, Tiziana Castrignanò, Piera Rizzolo, Daniela Barana, Veronica Zelli, Paolo Peterlongo, Giuseppe Giannini, Domenico Palli, Alessandra Viel, Valentina Silvestri, Giovanna Masala, Anna Sara Navazio, Marco Montagna, Paolo Radice, Virginia Valentini, Anna Coppa, Cristina Oliani, Antonio Russo, Maria Grazia Tibiletti, Laura Cortesi, Giovanni Chillemi, Jacopo Azzollini, Bernardo Bonanni, Bernard Peissel, Ines Zanna, Simona Agata, Siranoush Manoukian
Publikováno v:
Cancer. 123:210-218
BACKGROUND Male breast cancer (MBC) is a rare disease whose etiology appears to be largely associated with genetic factors. BRCA1 and BRCA2 mutations account for about 10% of all MBC cases. Thus, a fraction of MBC cases are expected to be due to gene